2017 Ross Prize in Molecular Medicine — Regulating Immunity: Fc Receptor Biology

The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries transformed the way medicine is practiced. The awardees are midcareer researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.

The 2017 Ross Prize in Molecular Medicine will be awarded to Dr. Jeffrey V. Ravetch for his vital discovery of the mechanism by which the specific structure of antibodies controls immune cell reactivity. This work unveils the fine line between normal immune responses—such as those that remove foreign pathogens—and autoimmunity; processes that govern countless diseases. Dr. Ravetch's work continues to elucidate the complex cellular signaling that governs this fulcrum of immunity, and it is with this knowledge that new therapies will be pursued.

Rafi Ahmed, PhD

Emory University

Klas Kärre, MD, PhD

Karolinska Institutet

Ronald Levy, MD

Stanford University

Jeffrey V. Ravetch, MD, PhD

The Rockefeller University

General Admission: $5.00

Although on-site registration may be possible on the day of the event, pre-registration is highly encouraged due to space limitations.